World Journal of Clinical Cases - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 34

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

217

HTML

3062

Figures (1-3)

412

Sum=3691

Publishing Process of This Article

Item

Count

Browse

144

Download

719

Sum=863

Dec 6, 2024 (publication date) through Apr 19, 2026

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Igata Y, Kudo M, Kojima M, Kami S, Aoki K, Satake T, Kobayashi T, Sugimoto M, Kobayashi S, Konishi M, Gotohda N. Conversion surgery after gemcitabine and cisplatin plus durvalumab for advanced intrahepatic cholangiocarcinoma: A case report. World J Clin Cases 2024; 12(34): 6721-6727 [PMID: 39650816 DOI: 10.12998/wjcc.v12.i34.6721]
URL:	https://www.wjgnet.com/2307-8960/full/v12/i34/6721.htm

Number	Citing Articles
1	Koshiro Fukuda, Akiyoshi Kasuga, Yasuyuki Shigematsu, Kenichiro Kato, Hiromichi Ito, Arisa Ueki, Takeshi Okamoto, Masato Ozaka, Yu Takahashi, Naoki Sasahira. Pathological complete response following addition of durvalumab to gemcitabine and cisplatin therapy for intrahepatic cholangiocarcinoma with Lynch syndrome-associated mismatch repair deficiency. Clinical Journal of Gastroenterology 2025; 18(3): 520 doi: 10.1007/s12328-025-02122-1
2	Zun-Yi Zhang, Zhi-Yong Huang, Tong Yuan, Mi Zhou, Jun-Jie Liu. Conversion treatment for advanced intrahepatic cholangiocarcinoma: Opportunities and challenges. World Journal of Gastroenterology 2025; 31(15): 104901 doi: 10.3748/wjg.v31.i15.104901 Abstract(406) \| Core Tip(406) \| Full Article(HTML)(4011) \| Full Article with Cover (PDF)-1646K(171) \| Audio-361K(37) \| Peer-Review Report-229K(91) \| Answering Reviewers-511K(89) \| Full Article (PDF)-1353K(227) \| Full Article (XML)-366K(88) \| Times Cited (6) \| Total Visits (8171) \| Open
3	雨马. Research Advances in the Molecular Mechanisms and Treatment of Intrahepatic Cholangiocarcinoma. World Journal of Cancer Research 2026; 16(02): 68 doi: 10.12677/wjcr.2026.162009